Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia in a Healio Video Perspective from Eyecelerator@AAO. The GenII device aims to improve near vision without affecting distance vision in patients with presbyopia. The company plans to conduct a study in the U.S. in 2026, with potential commercial availability in 2027. Lopez believes this solution can address the biomechanical issue of presbyopia, offering patients a natural way to regain near vision.
Source link
Laser scleral microporation may solve biomechanical problem of presbyopia
